加药
医学
重症监护医学
精密医学
风险分析(工程)
钥匙(锁)
药代动力学
人口
计算机科学
贝叶斯概率
梅德林
医学物理学
不利影响
作者
Rohith Anandan Prabakar,Abilash Reddybathini,Chandramouli Radhakrishnan,Muhasaparur Ganesan Rajanandh
标识
DOI:10.2174/0127724328461249260523072801
摘要
Recent advances in pediatric pharmacokinetics highlight substantial age-dependent physiological changes that require specialised approaches to optimise efficacy and minimise adverse effects in children. This review compares pharmacokinetic differences between adults and children, traditional dosing approaches, and recent developments in Model-Informed Precision Dosing (MIPD), with a focus on Population Pharmacokinetic (PopPK) and Physiologically Based Pharmacokinetic (PBPK) modeling strategies. Recent advances in Bayesian forecasting and the integration of artificial intelligence and machine learning are highlighted for their potential to improve dosing accuracy and clinical decision-making. This article examines current regulatory perspectives on pharmacometric approaches in pediatric medication development and offers insights into evolving standards and guidelines. It also addresses key technical, logistical, and regulatory challenges and potential solutions. Based on these insights, future strategies to improve model-based precision in pediatric dosing are discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI